Diabetes Research and Clinical Practice
Volume 66, Supplement , Pages S11-S17, December 2004

Islet transplantation: a realistic alternative for the treatment of insulin deficient diabetes mellitus

  • Kwang-Won Kim

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +82 2 3410 3430x3444; fax: +82 2 3410 0064.

Department of Medicine, Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University, School of Medicine, 50 Ilwon-Dong, Kangnam-Ku, SEOUL 135-230, Republic of Korea

Received 18 September 2003; accepted 16 October 2003. published online 19 August 2004.

Abstract 

Diabetes mellitus is a devastating disease and the WHO [World Health Report, World Health Organization, 2002] (World Health Organization) expects that the number of diabetic patients will increase to 300 million by the year 2025. Type 1 diabetes results from an autoimmune-mediated destruction of the insulin-secreting β-cells in the islets of Langerhans of the pancreas, whereas Type 2 diabetes is a disease of the older population which is due to systemic insulin resistance and reduced insulin secretion by the pancreatic β-cells. Surgical resection of the pancreas may also cause insulin-dependent diabetes depending on the size of the remaining pancreas. The long-term complications of diabetes are a direct result of the constantly elevated levels of blood glucose in the absence of an effective insulin treatment. Recent prospective studies such as the diabetes control and complication trial (DCCT) [N. Engl. J. Med. 329 (1993) 977] and the UK prospective diabetes study [Lancet 352 (1998) 837] have convincingly demonstrated that improved blood glucose control in all type diabetes reduces the risk of the development of the secondary complications of diabetes. Despite intensive insulin therapy, most individuals with insulin deficient diabetes are unable to maintain a blood glucose level in the normal range at all times. Therefore, the only way to ensure the long-term health of patients with diabetes is find a way of maintaining constant normoglycemia. It seems logical that the replacement of the islet tissue itself, either by transplanting a vascularized pancreatic allograft or by transplanting purified pancreatic islet cells, offers a better approach than simply replacing insulin that has been lost. In this article, we outline the major achievements made recently in the development of therapeutic islet transplantation applications and offer an explanation as to why islet transplantation seems to be an ideal solution for absolute insulin deficient diabetes.

Keywords:  Islet transplantation , Diabetes mellitus , Insulin deficiency

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(04)00152-4

doi:10.1016/j.diabres.2003.10.025

Diabetes Research and Clinical Practice
Volume 66, Supplement , Pages S11-S17, December 2004